Bausch Health Companies | VRX - Nettoeinkommen

Aktienkurs
7.42
Täglich Wechseln
0.09 1.16%
Monatlich
-6.02%
Jährlich
13.90%
Q2 Prognose
7.72




Nettoeinkommen Veränderung Datum
Amgen USD 1.82B 486M 2026-03
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bausch Health Companies USD -1.42B 1.31B 2026-03
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Danaher USD 1.03B 168M 2026-03
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Zoetis USD 601M 2M 2026-03